PLASMAPHERESIS DURING KIDNEY TRANSPLANTATION IN RECIPIENTS WITH ANTI-LEUKOCYTE ANTIBODIES


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper provides evidence for the high efficiency and relative safety of plasmapheresis in the complex of preparation in patients with anti-HLA antibodies for kidney transplantation and their postoperative management.

Full Text

Restricted Access

About the authors

E. Salimov

I.M. Sechenov First Moscow State Medical University

Email: dc13@mail.ru
Candidate of Medical Sciences Moscow

M. Kaabak

Acad. B.V. Petrovsky Russian Surgery Research Center

Professor, MD Moscow

A. Ragimov

I.M. Sechenov First Moscow State Medical University

Professor, MD Moscow

N. Dashkova

I.M. Sechenov First Moscow State Medical University

Professor, MD Moscow

A. Shcherbuk

I.M. Sechenov First Moscow State Medical University

Professor, MD Moscow

References

  1. Хубутия М.Ш., Боровкова Н.В., Доронина Н.В. и др. HLA-антитела и их значение при трансплантации почки // Трансплантология. - 2010; 3-4: 32-6.
  2. Ильинский И.М. и др. Патоморфология трансплантированных органов. Трансплантология. Руководство для врачей. Под ред. В.И. Шумакова / М., 2006; с. 472-538.
  3. Rebellato L. et al. Clinical and anti-HLA antibody profi le of nine renal transplant recipients with failed grafts: donor specifi c and non-donor-specific antibody development // Clin. Transplant. - 2006; 241-54.
  4. Сушков А.И., Абрамов В.Ю., Мойсюк Я.Г. Роль предсуществующих и de novo антидонорских антител при трансплантации почки // Вест. трансплантол. и искусственных органов. - 2011; XIII (1): 84-91.
  5. Terasaki P. Humoral theory of transplantation // Am. J. Transplant. - 2003; 3 (6): 665-73.
  6. Зарецкая Ю.М. Роль большого комплекса гистосовместимости в выживаемости аллогенного трансплантата. Клиническая иммуногенетика / М.: Медицина, 1983; с. 108-25.
  7. Terasaki P., Ozawa M. Predicting Kidney Graft Failure by HLA Antibodies: A Prospective Trial // Am. J. Transplant. - 2004; 4 (3): 438-43.
  8. Zhang. Q. et al. Development of posttransplantationdonor HLA antibodies is associated with acute humoral rejection and early graft dysfunction // Transplantation. - 2005; 79 (5): 591-8.
  9. Bartel G. et al. Peritransplantion immunoadsorption for positive crossmatch deceased donor kidney transplantation // Am. J. Transplant. - 2010; 10 (9): 2033-42.
  10. Hardinger K., Alford K., Murillo D. Bortezomib for acute humoral rejection in two repeat transplant recipients // Clin. Transplant. - 2009; 479-83.
  11. Yuan X. et al. Kidney transplant in highly sensitized patients after desensitization with plasmapheresis and low-dose intravenous immunoglobulin // Exp. Clin. Transplant. - 2010; 8 (2): 130-5.
  12. Nishikawa K., Terasaki P. Annual trends and triple therapy - 1991-2000 // Clin. Transplant. - 2001; 247-69.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies